Clinical Trial Update: Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pre- versus post-operative misoprostol to reduce blood loss after cesarean section; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section-related Blood Loss
• Misoprostol Allergy

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Cairo University | Conditions: Misoprostol Allergy | Phase 4 | Status: UNKNOWN